What should we be focusing on in CLL research?
Developing targeted therapies to combine with venetoclax in acute myeloid leukemia (AML)
Treating acute myeloid leukemia with VALOR – vosaroxin in combination with cytarabine
Overview of research in Waldenström’s macroglobulinemia therapies
A follow-up from the CASTOR trial evaluating daratumumab with bortezomib for the treatment of MM